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Polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) is a versatile nano-
composite biomaterial with growing applications as a bioscaffold for tissue engineering. Integration of
synthetic implants with host tissue can be problematic but could be improved by topographical modi-
ﬁcations. We describe optimization of POSS-PCU by dispersion of porogens (sodium bicarbonate
(NaHCO3), sodium chloride (NaCl) and sucrose) onto the material surface, with the principle aim of
increasing surface porosity, thus providing additional opportunities for improved cellular and vascular
ingrowth. We assess the effect of the porogens on the material's mechanical strength, surface chemistry,
wettability and cytocompatibilty. Surface porosity was characterized by scanning electron microscopy
(SEM). There was no alteration in surface chemistry and wettability and only modest changes in me-
chanical properties were detected. The size of porogens correlated well with the porosity of the construct
produced and larger porogens improved interconnectivity of spaces within constructs. Using primary
human bronchial epithelial cells (HBECs) we demonstrate moderate in vitro cytocompatibility for all
surface modiﬁcations; however, larger pores resulted in cellular aggregation. These cells were able to
differentiate on POSS-PCU scaffolds. Implantation of the scaffold in vivo demonstrated that larger pore
sizes favor cellular integration and vascular ingrowth. These experiments demonstrate that surface
modiﬁcation with large porogens can improve POSS-PCU nanocomposite scaffold integration and suggest
the need to strike a balance between the non-porous surfaces required for epithelial coverage and the
porous structure required for integration and vascularization of synthetic scaffolds in future construct
design.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Tissue engineering is evolving with a plethora of candidate
scaffold materials [1]. Clinically, a number of organs have now been
transplanted using artiﬁcial scaffolds including bladder, esophagusCentre, UCL Respiratory, Uni-
C1E 6JF, UK.
and Ear Hospital, 330 Gray's
Birchall), s.janes@ucl.ac.uk
Ltd. This is an open access articleand trachea [2,3]. The optimal scaffold material in each setting
remains undetermined with debate largely focused on whether
biological (e.g. decellularized) or synthetic material is most
appropriate [4,5]. Whilst the former is often considered superior as
it mimics native tissue, it is wholly reliant on procuring donor tis-
sue [6]. Synthetic biomaterials have the potential to overcome this
problem and advances in manufacturing techniques, including
surface modiﬁcations, mean synthetics hold increasing promise
[7,8].
Polyhedral-oligomeric silsesquioxane (POSS), (RSiO3/2) incor-
porated into poly(carbonate-urea) urethane (PCU) is one such
synthetic material developed by our group [9]. As a nanocompositeunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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biostability, gas barrier, thermal stability, elastic modulus and
mechanical properties compared to other conventional micro-
composites [10,11]. This is because its smaller particle size leads to
an increase surface to volume ratio, permitting a higher number of
reactions to occur on the particle surface [12]. Extensive testing has
conﬁrmed this material meets international standards (ISO 10993)
for biocompatibility, supporting various cell types [13,14] and a
number of tissues/organs have now been created using POSS-PCU,
including trachea [15], facial organs [16,17], lacrimal ducts [18] and
vascular bypass grafts [19e21]. Transcatheter heart valves and
coronary artery bypass grafts using POSS-PCU are undergoing pre-
clinical and clinical trials [20,22].
Organs that form tubular conduits, such as trachea and esoph-
agus, are a challenge for bioengineers as they represent an interface
with the outside environment, making barrier function essential
[23e26]. Current use of POSS-PCU involves a semi-closed pore
design to help maintain this surface integrity. However, such an
approach could limit delivery of nutrients and metabolites within
the implanted material. Adequate porosity of the scaffold has been
shown to improve outcomes in tissue-engineered bone and carti-
lage where it is essential to permit neoangiogenesis [27]. As such,
future scaffold designs should incorporate a degree of permeability
to encourage tissue engraftment and angiogenesis [28]. We have
attempted to address this challenge by using a variety of porogens
in the manufacture process of POSS-PCU scaffolds. Permeability,
surface and biomechanical properties were characterized following
porogen modiﬁcation. Cytocompatibility was demonstrated by
seeding primary human epithelial cells sourced from large airways
at varying seeding concentrations and examining cell viability,
proliferation and differentiation. The integration capacity of treated
and non-treated three-dimensional (3D) sheets of the POSS-PCU
foam-form elastomer was determined by implantation in vivo.
2. Materials and methods
2.1. POSS-PCU nanocomposite polymer synthesis and fabrication
POSS-PCU was synthesized using a previously described tech-
nique. Brieﬂy, trans-cyclohexanechloroydrinisobutyl-silsesquiox-
ane (Hybrid Plastics, USA) and polycarbonate polyol (2000 MW)
weremixed in a reaction ﬂask, heated to 115 C to dissolve the POSS
nanocage into the polyol and then cooled to 60 C. Flake 4,40-
methylene bis(phenyl isocyanate) was added to the polyol blend
and reacted under nitrogen for 120 min at 65 C to form a pre-
polymer. Dimethylacetamide (DMAC) was added slowly to the
pre-polymer to form a solution and was then cooled to 35 C. Chain
extension of the pre-polymer was carried out by the dropwise
addition of ethylenediamine in dimethylacetamide to form a so-
lution of POSS-modiﬁed polycarbonate urea-urethane in dimethy-
lacetamide. All chemicals and reagents were purchased from
SigmaeAldrich Ltd., Gillingham, UK.
The polymer was processed into a foam elastomer by coagu-
lating the polymer in water, leaving it for three days and changing
the water three times daily thereafter. Where indicated, the top
layer of the polymer was altered by dusting various porogen types
onto the surface. Three different porogenswere used, NaHCO3, NaCl
and sucrose. Each porogen typewas sprinkled onto a polymer sheet
(surface area of 64 cm2) and the dish was immersed in distilled
water. To determine the average grain size of each porogen type,
the porogens were imaged with scanning electron microscopy us-
ing a Jeol 7401 FEGSEM microscope. The porogens were sprinkled
onto aluminum stubs using sticky carbon tabs and coated with a
thin layer of Au/Pd (approximately 2 nm thick) using a Gatan ion
beam coater. The maximum diameter of each grain was thenmeasured using the measuring tool on the Joel software and the
mean was calculated using GraphPad prism.
2.2. Characterization of the 3D construct
2.2.1. Mechanical properties
The tensile properties of each sample were tested using an
Instron 5565 tester (Instron Ltd, Bucks, UK). Each sample was cut
into ﬁve dumbbell shapes using a template cutter and the sample
thickness was recorded. The tensile stress versus strain properties
were assessed according to ISO 37 using dumbbell-shaped spec-
imen type 3 (16 mm gauge length and 4 mm width) at a
displacement rate of 200 mm min1. Young's modulus was also
calculated using Bluehill software as the slope of the straight-line
portion between 0 and 5 mm.
2.2.2. Surface chemical properties using FTIR
The surface chemical composition of six of each sample typewas
characterized. Fourier Transform Infra-Red spectra were recorded
on a Jasco FT-IR 4200 Spectrometer equipped with a diamond
attenuated total reﬂectance accessory (Diamond MIRacle ATR, Pike
Technologies, USA). An average of 20 scans at 4 cm1 resolution
over a range of 600 cm1 to 4000 cm1 wavenumbers were per-
formed to produce the spectra.
2.2.3. Surface hydrophobicity using captive bubble contact angle
Water contact angle analysis was used to determine the hy-
drophilicity/hydrophobicity of the material surface. The captive
bubble method for assessment was applied as this method does not
require the refabrication of samples, which can disturb prospective
nuances of the surface. The angle between an air bubble and the
POSS-PCU samples immersed in water was measured
(Supplementary Figure 1). Samples (n ¼ 6) were analyzed using a
KRÜSS DSA 100, Drop Shape Analyzer (KRÜSS GmbH, Hamburg,
Germany). The contact angles on both sides of the bubble were
calculated and averaged producing the overall theta value. Samples
were autoclaved prior to testing and analyzed with the treated side
in contact with the air bubble.
2.2.4. Permeability of 3D POSS-PCU scaffolds
The permeability of each scaffold type (n ¼ 3) was determined
using a custom-made apparatus designed to measure the ﬂow rate
of water through a 1 cm2 aperture containing the sample, with a
controlled pressure. The permeability was considered the degree of
ﬂow through a sample (ml/min).
2.2.5. Surface morphology using scanning electron microscopy
(SEM)
Scanning electron microscopy (SEM) images of the apical and
basal surfaces of the scaffold as well as scaffold cross sections were
taken. This was performed in the same way for seeded, unseeded
and implanted scaffolds. Samples were ﬁxed in 2.5% glutaraldehyde
in PBS. Following ﬁxation, scaffolds were washed in 0.1 M phos-
phate buffer (pH 7.4) followed by distilled water, dehydrated in a
graded ethanol-water series to 100% ethanol and critical point
dried using carbon dioxide. The samples were then mounted on
aluminum stubs using sticky carbon tabs, so that the surfaces of
interest were presented to the beam. Specimens were coatedwith a
thin layer of Au/Pd (approximately 2 nm thick) using a Gatan ion
beam coater and viewed using a Jeol 7401 FEGSEM. To quantify the
mean surface pore size of each scaffold type, Volocity software
(PerkinElmer) was used tomeasure themaximum diameter of each
pore and the mean was calculated using GraphPad Prism software
v6.
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2.3.1. Cell culture
Primary human bronchial epithelial cells (HBECs) were obtained
from regions of normal airway frompatients undergoing lobectomy
(Research Ethics Committee 06/Q0505/12) or purchased from Sci-
encell (California, USA).
Airway sections were cut macroscopically under sterile condi-
tions into 5 mm2 pieces and incubated in a solution of 0.15% (w/v)
pronase (Roche, Basel, Switzerland) in Dulbecco's modiﬁed Eagle's
medium (DMEM, PAA Laboratories GmbH, Pasching, Austria) at 4 C
overnight with agitation. This reaction was neutralized using 20%
fetal bovine serum (v/v; FBS; Life technologies, Carlsbad, CA, USA).
Primary cells were pelleted and resuspended in bronchial epithelial
growth medium (BEGM; CC-3170, Lonza, Switzerland) and seeded
at 1  106 cells/25 cm2 in tissue culture ﬂasks (Nunc International,
Penﬁeld, NY, USA). Cells were incubated at 37 C with 5% CO2 and
allowed to adhere for 24 h prior to medium change. Medium
changes were performed every 48e72 h. Cells were expanded to
passage 3 for all experiments.
2.3.2. Cell seeding and cell viability on scaffolds
POSS-PCU sheets were cut into circular discs to ﬁt 96-well plates
using a punch biopsy for both dusted and non-dusted samples
(n ¼ 3) and the discs were washed in distilled water 3 times a day
for 2 days in order to remove residual salt. The discs were sterilized
by autoclaving in distilled water at 120 C for 15 min and subse-
quently stored at 4 C until use [29]. The discs were then placed in
96-well plates under sterile conditions in BEGM overnight at 37 C
with 5% CO2. The next day the medium was removed by aspiration
and HBECs were seeded onto the scaffolds in BEGM at different
seeding densities (1, 2.5, 5 and 10) x 105 cells/cm2. Each seeding
density was repeated in triplicate on each scaffold type. Experi-
ments were repeated with cells from 3 different donors. Scaffolds
without cells were maintained in the same conditions as a negative
control. As a positive control, cells were seeded inwells coatedwith
50 mg/cm2 collagen IV (SigmaeAldrich, Gillingham, UK). Cell
viability and proliferation were assessed using an alamarBlue assay
(Invitrogen, Carlsbad, CA, USA) performed according to manufac-
turer's instructions. One day post seeding, scaffolds were trans-
ferred to a new 96-well plate to avoid false positive readings from
cells adhering to the tissue culture plastic rather than the scaffold.
Readings were taken at day 1, 2, 3, 4 and 5.
2.3.3. Immunocytochemistry, immunohistochemistry and
immunoﬂuorescence
HBECs grown in chamber slides (BD Biosciences, Franklin Lakes,
NJ, USA) were ﬁxed in 4% (w/v) paraformaldehyde (PFA, Sigma-
eAldrich, Gillingham, UK) in phosphate buffered saline (PBS, PAA
Laboratories GmbH, Pasching, Austria) for 10 min at room tem-
perature and kept in PBS for subsequent immunoﬂuorescence
staining. After 2 or 5 days of submerged culture, POSS-PCU scaffolds
were removed from plates and washed three times in PBS to
remove residual medium. The scaffolds were PFA-ﬁxed for
30 min at room temperature and washed three times in PBS before
immunoﬂuorescence staining. Samples retrieved from in vivo
studies were parafﬁn-embedded and sectioned for haematoxylin
and eosin (H&E), Masson's trichrome [22] and Periodic Acid Schiff
(PAS) staining. Slides were digitally imaged using a NanoZoomer
2.0-HT system and NanoZoomer Digital Pathology software
(Hamamatsu Photonics, Japan) at 40 magniﬁcation.
For immunoﬂuorescence, parafﬁn sections were dewaxed and
underwent antigen retrieval with citrate buffer. All samples were
blocked using 1% bovine serum albumin in PBS (w/v; BSA; Sigma-
eAldrich, Gillingham, UK) at room temperature, followed byincubation in primary antibody diluted in blocking solution plus
0.1% Triton X-100 (SigmaeAldrich, Gillingham, UK) for 2 h at room
temperature. Samples were washed three times with PBS and
species-appropriate Alexa Fluor-conjugated secondary antibodies
(Life Technologies, Paisley, UK), diluted 1:300 in block solution,
were applied for 1 h at room temperature. DAPI, diluted in PBS, was
applied to slides before a ﬁnal three washes in PBS and cover-
slipping. Epithelial cells were identiﬁed by using primary anti-
bodies against pan-cytokeratin (AE1/AE3 or ab9377; Abcam),
cytokeratin 5 (CK5; mouse-anti-human, clone XM26 or rabbit-anti-
human, polyclonal, Abcam), E-Cadherin (BD Biosciences, Oxford,
UK), MUC5B (HPA008246; SigmaeAldrich, Gillingham, UK), ACT
(T6793; SigmaeAldrich, Gillingham, UK), Ki67 (M7240; Dako) and
Alexa Fluor 488-conjugated phalloidin to stain actin (Life Tech-
nologies, Paisley, UK). Endothelial cells were identiﬁed by an anti-
CD31 antibody (ab28364; Abcam). Images were acquired using
either a Zeiss LSM 500 confocal microscope (Carl Zeiss AG, Ober-
kochen, Germany) or an EVOS Imaging System (Life Technologies,
Paisley, UK).2.3.4. Sterilization of POSS-PCU scaffolds
POSS-PCU scaffolds were sterilized either by autoclave at 120 C,
15 psi above atmospheric pressure for 15 min or ethanol-cleansed
by submerging scaffolds in 70% ethanol for 30 min followed by
repeated PBS washing.2.3.5. Differentiation of HBECs on unmodiﬁed POSS-PCU scaffolds
HBECs (Sciencell, California, USA) were cultured in bronchial
epithelial cell medium (BEpiCM, Sciencell, California, USA), trypsi-
nized and viable cells counted using trypan blue staining (Life
Technologies, Paisley, UK). Cells were seeded to be conﬂuent at 24 h
onto either Falcon 0.4 mm pore size polyethylene terephthalate
(PET; Becton Dickinson Labware, Claix, France) as a positive control
or POSS-PCU sheets clipped with Cellcrown (SigmaeAldrich, Gil-
lingham, UK) to create a POSS-PCU transwell insert. 500 mL of
Pneumacult-ALI (STEMCELL Technologies, Cambridge, UK) was
added into the lower chamber of each well while cells were seeded
in a 200 mL volume in the upper compartment. After three days of
submerged culture, scaffolds were air-lifted by adding 1 mL of
Pneumacult-ALI to the basal chamber and removing media from
the upper chamber to generate an air-liquid interface.2.4. In vivo scaffold integration experiments
Scaffold discs were implanted either subcutaneously or into the
dorsal muscle of C57BL/6 mice for 4 or 8 weeks. The study was
approved by University College London ethics committee and
performed under Project License PPL70/7504. Mice were obtained
from an inbred colony, housed in individually ventilated cages
(IVC). General anesthesia was induced and maintained by a 1e3%
isoﬂurane/oxygen mix. Analgesia included carprofen (0.005 mg/kg
s/c) and buprenorphine (0.01 mg/kg s/c) given at induction. Im-
plantation of scaffold materials were performed through a 8 mm
‘off-midline’ dorsal incision and creating subcutaneous pockets in
four quadrants over the dorsum. Scaffolds were implanted in two
subcutaneous pockets and two muscle pockets. For muscle im-
plantation, perimysium fascia was identiﬁed through a subcu-
taneous pocket and scaffolds implanted in the substance of the
muscle. Animals were recovered and monitored daily. Post-
operative analgesia (carprofen; 0.005mg/kg s/c) was given for 24 h.
Animals were terminated at 4 weeks or 8 weeks post implantation
and scaffolds retrieved for analysis.
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Datawere analyzed using GraphPad Prismv6. ANOVA or Kruskal
Wallis tests were applied as described in ﬁgure legends. p-values
<0.05 were considered statistically signiﬁcant.3. Results
3.1. POSS-PCU polymer characterization after porogen dusting
3.1.1. Mechanical properties
POSS-PCU scaffolds were dusted with three different sized
porogens; NaHCO3, NaCl or sucrose. Mechanical properties were
compared to non-dusted controls. A signiﬁcant difference in
maximum stress (p < 0.05) was only observed between the non-
dusted control and NaHCO3-dusted samples (Fig. 1A). While no
signiﬁcant differences were observed in total strain (Fig. 1A), aFig. 1. Characterization of POSS-PCU scaffolds of varying surface porosities. (A) Scaffolds we
showed minimal changes between scaffolds. (B) ATR-FTIR spectroscopy demonstrated no
remained unchanged. (D) Permeability testing revealed the most signiﬁcant changes follow
were performed in triplicate and analyzed using a KruskaleWallis test with Dunn's correctiosigniﬁcant increase in Young's modulus was observed between the
non-dusted control and both the NaHCO3- and the NaCl-dusted
samples (Fig. 1A).3.1.2. Surface chemistry
The surface chemistry of each sample was characterized using
Attenuated Total Reﬂectance - Fourier Transform Infra-Red (ATR-
FTIR) spectrometry. We observed the same spectra in all samples,
with identical peaks showing absorption bands characteristic of
poly(carbonate-urea-urethane). The largest absorptions occurred
at 1737.55 cm1 (carbonate C]O stretching from carbonate) and
1241.93 m1 (carbonate CeOeC stretching; Fig. 1B). The absorption
band for POSS is observed at 1111.76 cm1, typical for POSS con-
taining polyurethane (Fig. 1B). FTIR testing conﬁrmed that the
surface chemistry remained unaltered following fabrication. Ab-
sorption bands for all scaffolds were characteristic of
poly(carbonate-urea) urethanes and conﬁrmed that the addition ofre analyzed for their maximum stress, percentage strain and Young's modulus, which
changes between scaffolds. (C) Surface wetness via captive bubble contact angle also
ing dusting with sucrose, which increased ﬂow rate through the scaffold. Experiments
n for multiple comparisons. Statistical signiﬁcance is displayed as *p < 0.05, **p < 0.01.
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surface.
3.1.3. Contact angle
Despite a small increase in contact angle in the NaCl-dusted
samples, there was no signiﬁcant difference between dusted sam-
ples and non-dusted controls (Fig. 1C).
3.1.4. Permeability
The rate at which water passes through the sample at a starting
pressure of 40 mmHg was calculated. Increasing the porogen size
used to dust the scaffolds increased the water ﬂow rate through the
scaffold. Therefore, the sucrose-dusted scaffold was the most
permeable with an average ﬂow rate of 3.59 ml/s (Fig. 1D).
3.1.5. Scanning electron microscopy (SEM)
SEMwas used to quantify the average grain size of each porogen
type and results showed that NaHCO3, NaCl and sucrose had
increasing sizes respectively (Fig. 2A). SEM images of the top sur-
faces of dusted POSS-PCU scaffolds revealed that larger porogens
produced larger pores (Fig. 2B) with marked differences in surface
topography (upper panel; Fig. 2C). The inner material of the poly-
mer remained equally porous across the different dustings asFig. 2. Surface topography of surface-dusted scaffolds. (A) Porogen size analysis using scan
each porogen type. (B) Analysis of pore size generated by each porogen in the scaffold (n ¼ 5
bar ¼ 100 mm).expected (lower panel; Fig. 2C).
3.2. Effects of POSS-PCU dusting on epithelial cytocompatibility
3.2.1. Cell characterization
Human bronchial epithelial cells (HBECs) were derived from
primary tissue and grown in submerged culture [30]. Staining with
antibodies against cytokeratin 5 (CK5) and cytokeratin 14 (CK14)
identiﬁed them as basal epithelial progenitor cells (Supplementary
Figure 2AeC). Staining with an antibody against Ki67, a marker of
cellular proliferation, showed the cells were actively proliferative
on tissue culture plastic (Supplementary Figure 2D).
3.2.2. Epithelial cell viability, growth, adherence and survival on
POSS-PCU
Cell metabolic activity measurements using the alamarBlue
assay showed that one day after seeding with four different cell
densities, there were signiﬁcantly fewer cells attached to the POSS-
PCU scaffolds compared to a collagen-coated plastic control (Fig. 3).
The metabolic activity of the cells on the control plastic increased
up to day 3 and then reached a plateau at cell conﬂuence. There
were no signiﬁcant differences in cellular metabolic activity be-
tween the dusted scaffolds at any time point across all seedingning electron microscopy (SEM) images and mean maximum diameter determined for
0). (C) SEM images of the apical surface and a cross section of candidate scaffolds (scale
Fig. 3. Human bronchial epithelial cell (HBEC) adherence, survival and growth on POSS-PCU. Metabolic activity of the cells on the four different scaffolds and the collagen-coated
tissue culture plastic (TCP) control over 5 days are expressed as the percentage of alamarBlue reduced in the cells during the incubation. Experiments were performed in triplicate
and analyzed using two-way ANOVA tests with Bonferroni post-tests. Statistical signiﬁcance is displayed as *p < 0.05, **p < 0.01, ***p < 0.001.
Fig. 4. Human bronchial epithelial cells (HBECs) adhere but cluster on surface-modiﬁed POSS-PCU scaffolds. HBECs seeded on the scaffolds at 1  106 cells/cm2 were
glutaraldehyde-ﬁxed two days post seeding and imaged by scanning electron microscopy. Top and middle rows show the dusted surface of the scaffolds at 75 and 400,
respectively. Third row shows magniﬁed inserts of scanning electron microscope pictures demonstrating HBECs adhering to the scaffolds with evidence of early stages of cyto-
skeleton development, extrusion of podia and ﬂattening. Bottom panel shows a cross section of the scaffolds at 75 magniﬁcation.
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showed signiﬁcantly higher metabolic activity on all the POSS-PCU
scaffolds, indicating that large cell numbers are required for
epithelial engraftment on these constructs (Fig. 3).
SEM images taken two days after seeding with 1 106 cells/cm2
showed that the cells were evenly spread on the surface of the non-
dusted and the NaHCO3-dusted scaffolds, which have small surface
pores (Fig. 4). However, cells on the surface of NaCl and sucrose-
dusted scaffolds had accumulated within the large pores (upper
right panels; Fig. 4). Some cells appeared to weakly adhere to the
scaffolds and showed early stages of cytoskeletal development and
focal adhesion (Fig. 4). Notably, many of the cells within larger
pores on the surface appeared to adhere to each other rather than
to the scaffold surface, forming cellular aggregates. In all scaffolds
except the non-dusted control, the cells appear to penetrate into
the scaffolds through communicating pores (bottom panel; Fig. 4).
Immunoﬂuorescence staining for CK5 conﬁrmed the clustering of
cells within the pores (Supplementary Figure 3).
3.2.3. Ethanol treatment improves cytocompatibility of non-dusted
POSS-PCU scaffolds and allows epithelial differentiation
Having demonstrated adhesion of HBECs to POSS-PCU scaffolds,
we attempted to culture cells for longer periods on non-dusted
scaffolds but met limited success using autoclaved scaffolds. To
address this issue we investigated whether the sterilization tech-
nique can affect the properties of POSS-PCU, ﬁnding that ethanol
treatment produced scaffolds with a contact angle comparable to
that of tissue culture plastic (Supplementary Figure 4A). Seeding
with HBECs revealed that, while metabolic activity declined on
autoclaved POSS-PCU over the course of two weeks of culture, it
was retained on ethanol-treated scaffolds (Supplementary
Figure 4B). Cells on ethanol-treated, non-dusted POSS-PCU retainFig. 5. Integration of surface-modiﬁed POSS-PCU scaffolds after subcutaneous or intramu
scaffolds at 4 weeks and 8 weeks post implantation. Scaffolds were either implanted subcu
cell inﬁltration into scaffolds and Masson's trichrome [22] shows matrix deposition. These hi
have been implanted in muscle at both early and late time points and subcutaneously at than epithelial morphology (Supplementary Figure 4C). Given the
ability of these scaffolds to maintain the viability of HBECs, we
investigated whether cells could differentiate to form the func-
tional cell types of the airway (mucosecretory goblet cells and
ciliated cells) on POSS-PCU. After three weeks of culture at an air-
liquid interface (ALI) cells formed a multi-layered epithelium with
evidence of both secretory (MUC5B; Supplementary Figure 4D) and
ciliated cell differentiation (ACT; Supplementary Figure 4De4E).
3.3. Sucrose dusting of POSS-PCU leads to increased cellular
inﬁltration and matrix deposition in vivo
Integration of scaffolds within a host tissue is a huge challenge
in synthetic polymer bioengineering [31] so we examined the
integration of surface-modiﬁed POSS-PCU in vivo. Scaffolds can be
implanted as a free graft or on a pedicled vascular ﬂap to improve
revascularization, so discs were implanted either subcutaneously
or into the dorsal muscle of C57BL/6 immunocompetent mice and
harvested after 4 or 8 weeks. We compared non-dusted scaffolds to
sucrose-dusted scaffolds given that these had the largest pore size
and permeability of our surface-modiﬁed scaffolds. All animals
survived with no adverse reactions to the grafts. On macroscopic
inspection, sucrose-dusted samples appeared better integrated
than non-dusted samples. Haematoxylin and eosin (H&E) staining
conﬁrmed enhanced cellular integration in the sucrose-dusted
scaffolds compared to the non-dusted samples (Fig. 5). Further,
Masson's trichrome staining demonstrated matrix deposition
within the pores, which was more evident in themuscle-implanted
samples compared to those implanted subcutaneously (Fig. 5). H&E
staining also revealed differences in the time taken to recellularize
the graft with an advantage conferred by muscle implantation.
Individual pores had increased numbers of cells in the sucrose-scular implantation. Histology images of implanted sucrose-dusted and non-dusted
taneously or into muscle. Staining with haematoxylin and eosin (H&E) demonstrates
ghlight a signiﬁcant cell inﬁltrate and matrix deposition in sucrose-dusted scaffolds that
e later 8 week time point (scale bar ¼ 100 mm).
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noﬂuorescence for the nuclear marker DAPI demonstrated
increased nuclear counts in the center of the graft, suggesting
improved cell ingrowth in scaffolds with larger pores (Fig. 6).
Staining for the endothelial cell marker CD31 conﬁrmed evidence
of increased neovascularizationwithin the sucrose-dusted scaffolds
(Fig. 6).
SEM images provide insight into the effect of dusting POSS-PCU
dusting on cell ingrowth in vivo. Non-dusted samples had a sheet-
like capsule structure surrounding the scaffold surface, suggesting
that small pores were a barrier to integration. On the other hand,
dusted samples demonstrated matrix deposition within the scaf-
fold pores (Fig. 7) consistent with our data that these integrated
more readily with host tissue in vivo.
4. Discussion
Various methods of creating pores within materials exist,
including gas forming, phase separation, freeze-drying and salt
leeching, described in detail by Lon et al. [32]. Here, we describe
methods for altering surface topography and porosity of POSS-PCU
using three different porogens, NaHCO3, NaCl and sucrose, and
characterize the effects of these modiﬁcations on material prop-
erties, cytocompatibility and in vivo response.
The POSS-PCU constructs used for hollow organ design have
aimed principally to maintain barrier function, an application for
which a closed (minimal) pore design is logically best suited. This
creates a uniform surface but, as a result, the potential oxygen
gradient between the luminal surface and the external surface ofFig. 6. Sucrose dusting of POSS-PCU increases neo-vascularization in vivo. Immunoﬂuoresc
weeks post implantation. Scaffold edges are highlighted by dotted lines. DAPI nuclear counte
scaffolds, where cells are present throughout the graft. CD31 staining (white arrows) conﬁthe graft may be large, exposing luminal cells to hypoxic conditions
and poor gas exchange [33]. Determining the optimal scaffold
porosity is essential for the delivery of metabolites and to create an
appropriate microenvironment for vascular ingrowth. Open,
interconnecting pores could provide mechanical support but at the
same time act as a physical stimulus to guide and promote tissue
and vascular regeneration [32]. Additionally, pores on the surface of
the scaffold might facilitate interlocking between the scaffold and
surrounding tissues, thereby providing increased overall mechan-
ical stability to the implant [34]. Design of a scaffold that can pro-
vide this stability combined with adequate delivery of metabolites
and maintained luminal barrier function will be important for
improving clinical delivery of synthetic scaffolds.
Importantly, the introduction of pores into POSS-PCU through
dusting did not lead to diminished structural integrity. These data
are reassuring but mechanical differences may become apparent
when scaffolds are up-scaled to tissue/organ-speciﬁc sizes. Since
POSS-PCU constructs can be manufactured as composites consist-
ing of both the solid- and the foam-form elastomers, such de-
ﬁciencies could be readily accommodated by scaffold design. This is
particularly relevant for the trachea where the solid-form of POSS-
PCU provides the mechanical strength in the ‘c’-shaped rings and
the foam-form provides the softer interconnecting struts to pro-
duce a biomimetic scaffold reminiscent of native tissue [15].
We conﬁrmed by FTIR and contact angle analysis that modiﬁ-
cations would not alter POSS-PCU chemistry or surface wetness.
We measured permeability as a surrogate measure of inter-
connecting pores, which would ultimately be necessary for tissue
ingrowth. Untreated POSS-PCU has a small surface pore size ofence staining of implanted sucrose-dusted and non-dusted samples at 4 weeks and 8
r stain shows minimal cell inﬁltrate in untreated scaffolds compared to sucrose-dusted
rms the presence of vessels within the sucrose-dusted scaffold (scale bar ¼ 100 mm).
Fig. 7. Integration of POSS-PCU is improved by increased surface porosity conferred by surface dusting. Scanning electron microscopy (SEM) images of implanted dusted and non-
dusted POSS-PCU scaffolds at 4 and 8 weeks post implantation in cross section. Non-dusted scaffolds consistently demonstrated a capsule-like structure with minimal integration
compared to sucrose-dusted POSS-PCU scaffolds, which showed tissue ingrowth into individual pores.
C. Crowley et al. / Biomaterials 83 (2016) 283e293 291approximately 20 mm. Dusting opened these pores and perme-
ability tests showed treatment with sucrose, the largest porogen,
improved porosity more than either NaHCO3 or NaCl. There is ev-
idence that capillary ingrowth into biomaterials is most encour-
aged with pores of between 40 mm and 600 mm [35] and here we
generated pores of approximately 600 mm (sucrose treated) 350 mm
(NaCl-treated) and 50 mm (NaHCO3-treated) (Fig. 2). The penetra-
tion of the porogens into the scaffold is dependent on a number of
factors. These include the porogen type, the amount of porogen
used and the duration of time between dusting the polymer and its
immersion in water. Therefore, the depth of the pores can be
controlled. In this study, we immediately placed the dishes inwater
following dusting to allow limited time for the porogens to sink into
the polymer. Our ongoing and future research aims to determine
the optimum penetration of the porogen and to validate this within
our protocol.
Given the necessity for barrier function in tubular constructs
[36], we determined whether porogen modiﬁcations would be
detrimental to epithelial engraftment. POSS-PCU was broadly
cytocompatible, with or without dusting modiﬁcations. Ethanol
sterilization of non-dusted POSS-PCU scaffolds allowed improved
epithelialization and large pore size also appears to have improvedepithelial cell attachment in vitro. However, this latter result may be
explained by cell aggregation within pores, rather than by cohesive
engraftment as an epithelial sheet. Dusting appears poorly suited to
ex vivo epithelialization due to disruption of the ﬂat luminal sur-
face. However, current untreated synthetic scaffolds will also
require signiﬁcant improvements to promote epithelial attachment
[37]. Future modiﬁcations could include functionalizing the scaf-
fold with peptides [35], growth factors [38] or antibodies [39,40];
plasma-enhanced chemical vapor deposition techniques [41];
addition of stromal and/or endothelial cells [42]; and chemical/
biochemical patterning of the scaffold surface via microcontact
printing [43]. Current work is in progress to enhance the surface
properties using suchmethodologies as well as to 3D print scaffolds
with deﬁned topographical structures [44,45].
Importantly, we demonstrated that sucrose dusting and the
consequent generation of interconnecting pores increased cell
ingrowth in vivo. Even at eight weeks post transplantation, non-
dusted scaffolds had not integrated well with host tissue. Inter-
estingly, dusted scaffolds implanted in muscle showed tissue
ingrowth, neoangiogenesis and matrix deposition much earlier
than those implanted subcutaneously. This suggests the impor-
tance of implantation into a well-vascularized site for rapid
C. Crowley et al. / Biomaterials 83 (2016) 283e293292integration and will guide studies assessing the period of time that
full-sized scaffolds might require prior to clinical orthotopic
transplantation.
Overall, our results indicate that, while future modiﬁcations of
the apical surface of POSS-PCU will be necessary in organs with a
barrier function, dusting of POSS-PCU scaffolds may signiﬁcantly
improve their integration into host tissue.
5. Conclusion
The methods described here allow the controlled modiﬁcation
of the surface of POSS-PCU scaffolds. Porogen dusting of POSS-PCU
increases graft integrationwith surrounding host tissues, including
vascular ingrowth. The ability to manipulate porosity represents a
sizable advancement for POSS-PCU and increases the scope of
current and future POSS-PCU applications.
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